title: Identifying causal networks linking cancer processes and anti-tumor immunity using Bayesian network inference and metagene constructs.
abstract: Cancer arises from a deregulation of both intracellular and intercellular networks that maintain system homeostasis. Identifying the architecture of these networks and how they are changed in cancer is a pre-requisite for designing drugs to restore homeostasis. Since intercellular networks only appear in intact systems, it is difficult to identify how these networks become altered in human cancer using many of the common experimental models. To overcome this, we used the diversity in normal and malignant human tissue samples from the Cancer Genome Atlas (TCGA) database of human breast cancer to identify the topology associated with intercellular networks in vivo. To improve the underlying biological signals, we constructed Bayesian networks using metagene constructs, which represented groups of genes that are concomitantly associated with different immune and cancer states. We also used bootstrap resampling to establish the significance associated with the inferred networks. In short, we found opposing relationships between cell proliferation and epithelial-to-mesenchymal transformation (EMT) with regards to macrophage polarization. These results were consistent across multiple carcinomas in that proliferation was associated with a type 1 cell-mediated anti-tumor immune response and EMT was associated with a pro-tumor anti-inflammatory response. To address the identifiability of these networks from other datasets, we could identify the relationship between EMT and macrophage polarization with fewer samples when the Bayesian network was generated from malignant samples alone. However, the relationship between proliferation and macrophage polarization was identified with fewer samples when the samples were taken from a combination of the normal and malignant samples. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:470-479, 2016.
authors.affiliation: Dept. of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, 25606.
authors.forename: Jacob L
authors.initials: JL
authors.lastname: Kaiser
authors.affiliation: Dept. of Chemical Engineering, West Virginia University, Morgantown, WV, 25606.
authors.forename: Cassidy L
authors.initials: CL
authors.lastname: Bland
authors.affiliation: Dept. of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, 25606.|Dept. of Chemical Engineering and Mary Babb Randolph Cancer Center, West Virginia University Morgantown, WV, 25606.
authors.forename: David J
authors.initials: DJ
authors.lastname: Klinke
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology*; D001499:Bayes Theorem; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology; D049109:Cell Proliferation / Q000187:drug effects; D058750:Epithelial-Mesenchymal Transition / Q000187:drug effects; D005260:Female; D006801:Humans; D007109:Immunity; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents
keywords: Bayesian networks; TCGA; intercellular networks; oncogenesis